Chest CT Without Contrast for Pulmonary Nodule Evaluation

Primary Recommendation

The American College of Radiology recommends a chest CT without IV contrast as the standard approach for evaluating pulmonary nodules, as contrast does not improve detection or characterization of the nodules themselves 1, 2
CT chest without IV contrast accurately identifies pulmonary nodules and is the standard imaging modality for nodule detection and follow-up, with the American College of Radiology citing its effectiveness 3, 4
The mean attenuation value of benign and malignant nodules on unenhanced CT is not significantly different, but multiple imaging features that increase malignancy risk are best appreciated on CT, according to the American College of Radiology 2
CT provides superior spatial localization and contrast resolution compared to chest radiography, allowing improved detection of small pulmonary nodules, as stated by the American College of Radiology 3, 4

The American College of Radiology suggests adding IV contrast only if you need to evaluate mediastinal/hilar lymphadenopathy, distinguish nodes from mediastinal vessels, or assess for skeletal metastases 3, 4
Contrast may be appropriate if there is concern for metastatic disease in patients with advanced stage cancer, numerous (≥3) or bilateral nodal metastases, or adenopathy ≥6 cm, according to the American College of Radiology 3, 4
There is insufficient evidence to support routine use of dual-phase CT (without and with contrast) for pulmonary nodule evaluation, as stated by the American College of Radiology 1, 2

Dynamic contrast-enhanced CT can quantify nodule vascularity, but this specialized technique is highly sensitive yet nonspecific, as inflammatory and infectious nodules also show high vascularity, according to the American College of Radiology 1, 2
A multicenter study of 356 indeterminate solid nodules showed that absence of enhancement had 98% sensitivity and 96% negative predictive value for benignity, but this technique is recommended primarily for nodules >2 cm and requires specialized protocols, as cited by the American College of Radiology 1, 2

The USPSTF guidelines recommend low-dose CT without contrast for lung cancer screening in patients with significant smoking history (≥20-30 pack-years), according to the American College of Radiology 4, 5
Patients with smoking history have 7-14% risk of synchronous second primary lung cancer when presenting with other malignancies, as stated by the American College of Radiology 4, 6, 7
For patients aged 50-80 years with ≥20 pack-year smoking history who currently smoke or quit within 15 years, annual low-dose CT screening is recommended by the USPSTF 5

The American College of Radiology advises against relying on chest radiography alone, as sensitivity for detecting pulmonary nodules is only 28% compared to CT 3, 6, 7
The American College of Radiology recommends avoiding routine ordering of dual-phase CT (without and with contrast), as there is no supporting literature for this approach in standard nodule evaluation 1, 2, 4
The American College of Radiology suggests avoiding ordering contrast-enhanced CT as the initial study unless you specifically need to evaluate for lymphadenopathy or metastatic disease beyond the lung parenchyma 3, 4